Diabetic retinopathy (DR) and other microvascular complications remain a major source of disability in patients with diabetes.The Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) (1) and the Action to Control Cardiovascular Risk in Diabetes (ACCORD) (2) trials demonstrated that...